Search research articles
Contact Us
Filters
Showing results (171-180 of 391) with videos related to
Page
of 40
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Carling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Nature Communications
|
May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression
Filip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Maulikkumar P Patel, Arda Cetin, Matthew Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
The CentiMarker Project: Standardizing Quantitative Alzheimer's disease Fluid Biomarkers for Biologic Interpretation
Guoqiao Wang, Yan Li, Chengjie Xiong, et al.
Journal of the International Neuropsychological Society : JINS
|
September 5, 2022
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease
Jessica Nicosia, Andrew J Aschenbrenner, David A Balota, et al.
Molecular Neurodegeneration
|
May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
Tim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S Research & Therapy
|
May 25, 2023
Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [<sup>18</sup>F]flortaucipir study
Antoinette O'Connor, David M Cash, Teresa Poole, et al.
The New England Journal of Medicine
|
November 30, 2022
Lecanemab in Early Alzheimer's Disease
Christopher H van Dyck, Chad J Swanson, Paul Aisen, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 2, 2023
Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
Shveta Bathla, Dibyadeep Datta, Feng Liang, et al.
Cell Stem Cell
|
June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons
Lucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Page
of 40
Search research articles
Search
Showing results (171-180 of 391) with videos related to
Sort By:
Page
of 40
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Carling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Nature Communications
|
May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression
Filip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Maulikkumar P Patel, Arda Cetin, Matthew Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
The CentiMarker Project: Standardizing Quantitative Alzheimer's disease Fluid Biomarkers for Biologic Interpretation
Guoqiao Wang, Yan Li, Chengjie Xiong, et al.
Journal of the International Neuropsychological Society : JINS
|
September 5, 2022
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease
Jessica Nicosia, Andrew J Aschenbrenner, David A Balota, et al.
Molecular Neurodegeneration
|
May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
Tim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S Research & Therapy
|
May 25, 2023
Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [<sup>18</sup>F]flortaucipir study
Antoinette O'Connor, David M Cash, Teresa Poole, et al.
The New England Journal of Medicine
|
November 30, 2022
Lecanemab in Early Alzheimer's Disease
Christopher H van Dyck, Chad J Swanson, Paul Aisen, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 2, 2023
Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
Shveta Bathla, Dibyadeep Datta, Feng Liang, et al.
Cell Stem Cell
|
June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons
Lucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Page
of 40